pfizer vaccine news - Search News

Pfizer, COVID-19

Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal. Pfizer and its German partner BioNTech sued Moderna in London in September 2022,

National Post · 1d

Updated Pfizer-BioNTech’s COVID-19 vaccine approved by Health Canada

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.

The Independent Singapore · 1d

HSA approves Pfizer’s new RSV vaccine

This is the first RSV vaccine approved in Singapore for use in older adults and pregnant individuals, providing critical protection to infants and seniors

Global News · 2d

Pfizer’s updated COVID-19 vaccine approved by Health Canada

The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant.

The Canadian Press on MSN · 2d

Health Canada approves Pfizer's updated COVID-19 vaccine, manufacturer says

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.

Pfizer withdraws sickle cell drug Oxbryta

Barron's on MSN · 5h

Pfizer’s Strategy Looks Shakier After Sickle-Cell Disappointment

The company said it was withdrawing Oxbryta, a daily pill for patients with the disease, a serious, lifelong condition.

The Wall Street Journal on MSN · 23h

Pfizer to Withdraw Sickle Cell Drug Oxbryta Lots from World-Wide Markets

The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the approved sickle cell patient population.

Seeking Alpha · 23h

Pfizer withdraws sickle cell drug Oxbryta over safety concerns

Pfizer (PFE) has voluntarily withdrawn all lots of its sickle cell disease drug Oxbryta, also known as voxelotor, over safety concerns. Read more here.

STAT21h

Pharmalittle: We’re reading about Pfizer pulling a sickle cell pill, Moderna getting scolded, and more

The High Court gave a mixed decision in July, ruling that one of Moderna’s two patents relating to the mRNA technology that ...

11h

Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price, says CEO

Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the ...

WETM-TV3h

Judge dismisses family lawsuit against Dept. of Defense after 24-year-old’s “vaccine-related” death

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

Pfizer Is Rising Past Covid-19

Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...

6hon MSN

Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...

CNET on MSN5d

What to Know About Novavax, the 'Other' COVID Vaccine

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

On the hunt for Novavax: Why people are seeking out the 'traditional' COVID vaccine

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Pfizer yanks sickle-cell treatment worldwide after possible link to deaths

Pfizer Inc. said late Wednesday it was withdrawing a sickle-cell drug from markets worldwide and discontinuing clinical ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics